Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126528161 | 12652816 | 1 | I | 20160808 | 20160815 | 20160815 | EXP | US-MYLANLABS-2016M1033700 | MYLAN | KING F, MORRIS NA, SCHMAHMANN JD. DELAYED POSTHYPOXIC LEUKOENCEPHALOPATHY: IMPROVEMENT WITH ANTIOXIDANT THERAPY. CASE-REP-NEUROL 2015;7(3):242-246. | 0.00 | Y | 0.00000 | 20160815 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126528161 | 12652816 | 1 | PS | MORPHINE | MORPHINE | 1 | Unknown | 200824 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126528161 | 12652816 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126528161 | 12652816 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126528161 | 12652816 | Hypoxia | |
| 126528161 | 12652816 | Leukoencephalopathy | |
| 126528161 | 12652816 | Overdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |